Yue Hui Su
Director/Board Member at MAKALOT INDUSTRIAL CO., LTD.
Yue Hui Su active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MAKALOT INDUSTRIAL CO., LTD. | Director/Board Member | 21/02/2011 | - |
| Independent Dir/Board Member | - | - | |
| IN WIN DEVELOPMENT INC. | Director/Board Member | 01/07/2015 | - |
| Independent Dir/Board Member | 01/07/2015 | - | |
| ENNOCONN CORPORATION | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| FORMOSA PHARMACEUTICALS, INC. | Director/Board Member | 09/07/2021 | - |
| Independent Dir/Board Member | 09/07/2021 | - | |
| CECI Engineering Consultants, Inc. | Director/Board Member | - | - |
| Soochow University /Taiwan/ | Corporate Officer/Principal | - | - |
Career history of Yue Hui Su
Former positions of Yue Hui Su
| Companies | Position | Start | End |
|---|---|---|---|
| TWI PHARMACEUTICALS INC | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| Soochow University | Corporate Officer/Principal | - | - |
| BANK OF KAOHSIUNG CO., LTD. | Director/Board Member | 20/06/2002 | - |
Training of Yue Hui Su
| National Taiwan University | Doctorate Degree |
Statistics
International
| Taiwan | 10 |
| China | 2 |
Operational
| Director/Board Member | 7 |
| Independent Dir/Board Member | 5 |
| Corporate Officer/Principal | 2 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Electronic Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| MAKALOT INDUSTRIAL CO., LTD. | Consumer Non-Durables |
| BANK OF KAOHSIUNG CO., LTD. | Finance |
| IN WIN DEVELOPMENT INC. | Electronic Technology |
| ENNOCONN CORPORATION | Electronic Technology |
| FORMOSA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| CECI Engineering Consultants, Inc. | |
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Yue Hui Su
- Experience
